Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Herzig

Showing results (111-120 of 169) with videos related to

Pageof 17
Sort By:
Blood|April 1, 1988
High-dose cytosine arabinoside and fractionated total-body irradiation: an improved preparative regimen for bone marrow transplantation of children with acute lymphoblastic leukemia in remissionP F Coccia, S E Strandjord, P I Warkentin, et al.
Amino Acids|April 6, 2007
Oxidative stress and inflammation in the pathogenesis of activated polyamine catabolism-induced acute pancreatitisM Merentie, A Uimari, M Pietilä, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1989
High-dose thiotepa with autologous bone marrow transplantation for metastatic malignant melanoma: results of phase I and II studies of the North American Bone Marrow Transplantation GroupS N Wolff, R H Herzig, J W Fay, et al.
Lancet (London, England)|March 24, 1984
Allogeneic bone-marrow transplantation for chronic myelogenous leukaemiaB Speck, M M Bortin, R Champlin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1983
Intensive melphalan chemotherapy and cryopreserved autologous bone marrow transplantation for the treatment of refractory cancerH M Lazarus, R H Herzig, J Graham-Pole, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 19, 2010
Biocompatible photocrosslinked poly(ester anhydride) based on functionalized poly(epsilon-caprolactone) prepolymer shows surface erosion controlled drug release in vitro and in vivoJ Mönkäre, R A Hakala, M A Vlasova, et al.
Blood|October 1, 1993
Choice of pretransplant treatment and timing of transplants for chronic myelogenous leukemia in chronic phaseJ M Goldman, R Szydlo, M M Horowitz, et al.
Blood|June 1, 1985
High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: a pilot studyS N Wolff, J Marion, R S Stein, et al.
Annals of Internal Medicine|June 15, 1993
High-dose weekly intravenous immunoglobulin to prevent infections in patients undergoing autologous bone marrow transplantation or severe myelosuppressive therapy. A study of the American Bone Marrow Transplant GroupS N Wolff, J W Fay, R H Herzig, et al.
Blood|March 1, 1995
High-dose etoposide, cyclophosphamide, and total body irradiation with allogeneic bone marrow transplantation for patients with acute myeloid leukemia in untreated first relapse: a study by the North American Marrow Transplant GroupR A Brown, S N Wolff, J W Fay, et al.
Pageof 17

Showing results (111-120 of 169) with videos related to

Sort By:
Pageof 17
Blood|April 1, 1988
High-dose cytosine arabinoside and fractionated total-body irradiation: an improved preparative regimen for bone marrow transplantation of children with acute lymphoblastic leukemia in remissionP F Coccia, S E Strandjord, P I Warkentin, et al.
Amino Acids|April 6, 2007
Oxidative stress and inflammation in the pathogenesis of activated polyamine catabolism-induced acute pancreatitisM Merentie, A Uimari, M Pietilä, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1989
High-dose thiotepa with autologous bone marrow transplantation for metastatic malignant melanoma: results of phase I and II studies of the North American Bone Marrow Transplantation GroupS N Wolff, R H Herzig, J W Fay, et al.
Lancet (London, England)|March 24, 1984
Allogeneic bone-marrow transplantation for chronic myelogenous leukaemiaB Speck, M M Bortin, R Champlin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1983
Intensive melphalan chemotherapy and cryopreserved autologous bone marrow transplantation for the treatment of refractory cancerH M Lazarus, R H Herzig, J Graham-Pole, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 19, 2010
Biocompatible photocrosslinked poly(ester anhydride) based on functionalized poly(epsilon-caprolactone) prepolymer shows surface erosion controlled drug release in vitro and in vivoJ Mönkäre, R A Hakala, M A Vlasova, et al.
Blood|October 1, 1993
Choice of pretransplant treatment and timing of transplants for chronic myelogenous leukemia in chronic phaseJ M Goldman, R Szydlo, M M Horowitz, et al.
Blood|June 1, 1985
High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: a pilot studyS N Wolff, J Marion, R S Stein, et al.
Annals of Internal Medicine|June 15, 1993
High-dose weekly intravenous immunoglobulin to prevent infections in patients undergoing autologous bone marrow transplantation or severe myelosuppressive therapy. A study of the American Bone Marrow Transplant GroupS N Wolff, J W Fay, R H Herzig, et al.
Blood|March 1, 1995
High-dose etoposide, cyclophosphamide, and total body irradiation with allogeneic bone marrow transplantation for patients with acute myeloid leukemia in untreated first relapse: a study by the North American Marrow Transplant GroupR A Brown, S N Wolff, J W Fay, et al.
Pageof 17